title: PAI-1 and diabetes: a journey from the bench to the bedside.
authors.affiliation: Cardiovascular Unit, Department of Medicine, University of Vermont Colchester Research Facility, Colchester, Vermont, USA. david.schneider@uvm.edu
authors.forename: David J
authors.initials: DJ
authors.lastname: Schneider
authors.forename: Burton E
authors.initials: BE
authors.lastname: Sobel
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D000818:Animals; D001026:Coronary Artery Bypass / Q000009:adverse effects; D003324:Coronary Artery Disease / Q000209:etiology* / Q000601:surgery; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications*; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D007333:Insulin Resistance / Q000502:physiology; D008297:Male; D009203:Myocardial Infarction / Q000209:etiology; D009765:Obesity / Q000150:complications; D017395:Plasminogen Activator Inhibitor 1 / Q000096:biosynthesis / Q000502:physiology*; D011817:Rabbits; D016032:Randomized Controlled Trials as Topic; D010959:Tissue Plasminogen Activator / Q000037:antagonists & inhibitors / Q000502:physiology
chemical_list: D007328:Insulin; D017395:Plasminogen Activator Inhibitor 1; D010959:Tissue Plasminogen Activator